Benedicte Jørgenrud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benedicte Jørgenrud has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Stig Tore Bogstrand
Section of Forensic Research, Department of Forensic Science, Oslo University Hospital
4 shared publications- Thomas Berg
Department of Forensic Sciences, Division of Laboratory Medicine, Section of Drug Abuse Research, Oslo University Hospital, 0456 Oslo, Norway
4 shared publications - Anners Lerdal
Department of Public Health and Interdisciplinary Health Sciences, University of Oslo, Oslo, Norway
3 shared publications - Matej Orešič
Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, FI- 20520 Turku, Finland
3 shared publications Saranda Kabashi
Department of Forensic Sciences, Oslo University Hospital, P.O. Box 4950 Nydalen, N-0424 Oslo, Norway
3 shared publications- Stig Tore Bogstrand
Department of Forensic Sciences, Oslo University Hospital , P.O. Box 4950 Nydalen, Oslo 0424
3 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Taylor & Francis in Substance Use & Misuse
- p. 1-10
Using PEth and AUDIT-4 to Detect Harmful Alcohol Use Among People with Severe Substance Use
People with severe substance use (PWSSU) face increased health risks, which contributes to higher mortality rates and reduced life expectancy. Concurrent harmful alcohol use may further exacerbate these risks but is often overlooked in this population. The aim of this study was to assess levels of harmful alcohol use among PWSSU. Participants were recruited from two sites in Oslo, Norway, that either shelters and/or treats PWSSU. Alcohol and substance use was assessed with self-report questionnaires and a blood sample. The blood sample was analyzed for 20 commonly used illicit and medicinal substances, ethanol and phosphatidylethanol (PEth). Harmful alcohol use was defined as AUDIT-4 ≥ 7 (men)/≥5 (women), having PEth concentration ≥ 300 nM, or both. Associations between harmful alcohol use and sex, age, and substance use profile were assessed. Of the 165 participants (70% male) included in the study, most (n = 94, 57%) stated opioids as their main substance, and polysubstance use was common (median substances in blood samples = 5). Alcohol use in the last 12 months was reported by 75% (n = 125) of the participants. Harmful alcohol use was detected in 28 (24%) of male participants and 23 (47%) of female participants. Being female, decreasing age, and reporting a non-opioid as main substance were associated with harmful alcohol use. A harmful drinking pattern was frequently observed among PWSSU, especially among women. In addition to treating excessive substance use in this underserved group, reduction of harmful alcohol use would be beneficial to reduce health risk.
- 12 May 2026
- Published by Taylor & Francis in Substance Use & Misuse
- p. 1-10
Open AccessUsing PEth and AUDIT-4 to Detect Harmful Alcohol Use Among People with Severe Substance Use
People with severe substance use (PWSSU) face increased health risks, which contributes to higher mortality rates and reduced life expectancy. Concurrent harmful alcohol use may further exacerbate these risks but is often overlooked in this population. The aim of this study was to assess levels of harmful alcohol use among PWSSU. Participants were recruited from two sites in Oslo, Norway, that either shelters and/or treats PWSSU. Alcohol and substance use was assessed with self-report questionnaires and a blood sample. The blood sample was analyzed for 20 commonly used illicit and medicinal substances, ethanol and phosphatidylethanol (PEth). Harmful alcohol use was defined as AUDIT-4 ≥ 7 (men)/≥5 (women), having PEth concentration ≥ 300 nM, or both. Associations between harmful alcohol use and sex, age, and substance use profile were assessed. Of the 165 participants (70% male) included in the study, most (n = 94, 57%) stated opioids as their main substance, and polysubstance use was common (median substances in blood samples = 5). Alcohol use in the last 12 months was reported by 75% (n = 125) of the participants. Harmful alcohol use was detected in 28 (24%) of male participants and 23 (47%) of female participants. Being female, decreasing age, and reporting a non-opioid as main substance were associated with harmful alcohol use. A harmful drinking pattern was frequently observed among PWSSU, especially among women. In addition to treating excessive substance use in this underserved group, reduction of harmful alcohol use would be beneficial to reduce health risk.
- Open Access
- 16 November 2025
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 61 (1)
Unveiling stages of change among medical inpatients with an increased-risk alcohol consumption—a cross-sectional study
Aims: Alcohol-related harm occurs at lower levels than previously recognized, warranting a need to identify mediators to reduce alcohol-associated risk in increased-risk drinkers. Stages of change (SOC) have been used to assess motivation for health behaviour alteration. The primary aim was to explore distribution on SOC among medical inpatients when comparing low-risk, increased-risk, and high-risk consumers as defined by Alcohol Use Disorder Identification Test-Consumption (AUDIT-C). Our secondary aim was to assess the distribution of SOC when consumption was stratified with a biomarker of alcohol use—phospatidylethanol 16:0/18:1. Methods: Cross-sectional study with three participating hospitals. Recruiting consecutive medical inpatients ≥18 years with regular alcohol consumption as screened by score ≥2 on the first question in AUDIT-C (N = 888). AUDIT-C score and SOC were assessed by questionnaires, and phospatidylethanol concentration in a blood sample. Odds ratios and the 95% confidence intervals were calculated through a univariate logistic regression analysis for each variable, and multivariable logistic regression models were then fit to calculate the adjusted odds ratio and 95% confidence interval. Results: Distributions of SOC differed between the three risk-groups. Distribution of SOC was comparable whether assessed by phospatidylethanol or AUDIT-C. Conclusions: Increased-risk consumers constitute the majority of those in action—the only stage associated with consecutive reduction in drinking. Potentially, these results can aid in reducing perceived barriers among health care professionals in screening and offering health advice to those with increased-risk consumption and inform further research on mediators in this subgroup.
- 16 November 2025
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 61 (1)
Open AccessUnveiling stages of change among medical inpatients with an increased-risk alcohol consumption—a cross-sectional study
Aims: Alcohol-related harm occurs at lower levels than previously recognized, warranting a need to identify mediators to reduce alcohol-associated risk in increased-risk drinkers. Stages of change (SOC) have been used to assess motivation for health behaviour alteration. The primary aim was to explore distribution on SOC among medical inpatients when comparing low-risk, increased-risk, and high-risk consumers as defined by Alcohol Use Disorder Identification Test-Consumption (AUDIT-C). Our secondary aim was to assess the distribution of SOC when consumption was stratified with a biomarker of alcohol use—phospatidylethanol 16:0/18:1. Methods: Cross-sectional study with three participating hospitals. Recruiting consecutive medical inpatients ≥18 years with regular alcohol consumption as screened by score ≥2 on the first question in AUDIT-C (N = 888). AUDIT-C score and SOC were assessed by questionnaires, and phospatidylethanol concentration in a blood sample. Odds ratios and the 95% confidence intervals were calculated through a univariate logistic regression analysis for each variable, and multivariable logistic regression models were then fit to calculate the adjusted odds ratio and 95% confidence interval. Results: Distributions of SOC differed between the three risk-groups. Distribution of SOC was comparable whether assessed by phospatidylethanol or AUDIT-C. Conclusions: Increased-risk consumers constitute the majority of those in action—the only stage associated with consecutive reduction in drinking. Potentially, these results can aid in reducing perceived barriers among health care professionals in screening and offering health advice to those with increased-risk consumption and inform further research on mediators in this subgroup.
- Open Access
- 18 November 2024
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 60 (1)
Assessing alcohol consumption across phosphatidylethanol levels using HDL-cholesterol as a predictor
Aims: Prior research has established a correlation between increases of High-Density Lipoprotein Cholesterol (HDL-C) levels and alcohol consumption. This study aimed to explore the association between phosphatidylethanol (PEth) levels and the amount of consumed ethanol, utilizing HDL-C as a surrogate marker on a population level. This endeavor offers an adjunct to other studies. Methods: PEth and HDL-C levels in 50 751 samples from 29 899 patients in Norway were measured simultaneously in whole blood and serum, respectively. Linear mixed model analyses were employed to assess HDL-C levels within different PEth intervals. Drawing on previous research indicating an increase of .0035 mmol/L in HDL-C per gram of pure ethanol consumed per day, and assuming no alcohol intake in the zero PEth group, we estimated mean daily ethanol intake at the group level for males in each PEth interval. Results: Results revealed a significant correlation between PEth and HDL-C levels (Spearman’s rho = .385 for women, .420 for men, P < .001). Estimated mean HDL-C levels indicated higher alcohol consumption with increasing PEth. Specifically, men with PEth values in the .031–0.100 μmol/L (22–70 ng/ml) interval were estimated to consume approximately mean 20 grams of ethanol daily, while those in the .301–0.500 μmol/L (212–351 ng/ml) PEth interval had an estimated mean daily ethanol intake of 51 grams. Conclusions: The results from this study suggest an approximate estimation of mean daily amounts of consumed ethanol at group levels in different PEth intervals, based on previously shown correlation of ethanol consumption and HDL-C increase.
- 18 November 2024
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 60 (1)
Open AccessAssessing alcohol consumption across phosphatidylethanol levels using HDL-cholesterol as a predictor
Aims: Prior research has established a correlation between increases of High-Density Lipoprotein Cholesterol (HDL-C) levels and alcohol consumption. This study aimed to explore the association between phosphatidylethanol (PEth) levels and the amount of consumed ethanol, utilizing HDL-C as a surrogate marker on a population level. This endeavor offers an adjunct to other studies. Methods: PEth and HDL-C levels in 50 751 samples from 29 899 patients in Norway were measured simultaneously in whole blood and serum, respectively. Linear mixed model analyses were employed to assess HDL-C levels within different PEth intervals. Drawing on previous research indicating an increase of .0035 mmol/L in HDL-C per gram of pure ethanol consumed per day, and assuming no alcohol intake in the zero PEth group, we estimated mean daily ethanol intake at the group level for males in each PEth interval. Results: Results revealed a significant correlation between PEth and HDL-C levels (Spearman’s rho = .385 for women, .420 for men, P < .001). Estimated mean HDL-C levels indicated higher alcohol consumption with increasing PEth. Specifically, men with PEth values in the .031–0.100 μmol/L (22–70 ng/ml) interval were estimated to consume approximately mean 20 grams of ethanol daily, while those in the .301–0.500 μmol/L (212–351 ng/ml) PEth interval had an estimated mean daily ethanol intake of 51 grams. Conclusions: The results from this study suggest an approximate estimation of mean daily amounts of consumed ethanol at group levels in different PEth intervals, based on previously shown correlation of ethanol consumption and HDL-C increase.
- Open Access
- 16 March 2024
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 59 (3)
Identifying excessive chronic alcohol use with phosphatidylethanol in patients with suspected severe injury-results from the IDART study
Introduction: Acute and chronic alcohol use are well-known risk factors for accidents and injuries, and concurrent psychoactive drug use can increase injury risk further. Phosphatidylethanol (PEth) 16:0/18:1 is a biomarker used to determine alcohol consumption the previous 3–4 weeks. The aim was to investigate the prevalence of chronic alcohol use in trauma patients, as determined by PEth 16:0/18:1 concentrations, and how excessive chronic alcohol use relate to demographic variables, injury mechanisms and drug use. Setting: Patients received at Norwegian trauma hospitals from March 2019 to February 2020. The study is part of the Impairing Drugs and Alcohol as Risk factors for Traumatic Injuries study. Methods: All patients aged ≥ 16 years received with trauma team were included in the study. Data on injury date and mechanism, gender and age was registered. Blood samples were analyzed for 22 psychoactive medicinal and illicit drugs, ethanol and phosphatidylethanol 16:0/18:1. Regression analyses were conducted to assess associations between alcohol use and gender, age, injury mechanism and drug use. Results and Conclusion: Of the 4845 patients included in the study, 10% had PEth 16:0/18:1 concentration ≥ 600 nM (~430 ng/mL), indicative of excessive chronic alcohol use. Being male, between 44-61 years old, involved in violence, and testing positive for medicinal drugs was associated with excessive chronic alcohol use. Excessive chronic alcohol use was common among males, middle-aged, patients with violence as injury mechanism and those with medicinal drug use. These findings emphasize the need to detect and treat excessive chronic alcohol use among trauma patients.
- 16 March 2024
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 59 (3)
Open AccessIdentifying excessive chronic alcohol use with phosphatidylethanol in patients with suspected severe injury-results from the IDART study
Introduction: Acute and chronic alcohol use are well-known risk factors for accidents and injuries, and concurrent psychoactive drug use can increase injury risk further. Phosphatidylethanol (PEth) 16:0/18:1 is a biomarker used to determine alcohol consumption the previous 3–4 weeks. The aim was to investigate the prevalence of chronic alcohol use in trauma patients, as determined by PEth 16:0/18:1 concentrations, and how excessive chronic alcohol use relate to demographic variables, injury mechanisms and drug use. Setting: Patients received at Norwegian trauma hospitals from March 2019 to February 2020. The study is part of the Impairing Drugs and Alcohol as Risk factors for Traumatic Injuries study. Methods: All patients aged ≥ 16 years received with trauma team were included in the study. Data on injury date and mechanism, gender and age was registered. Blood samples were analyzed for 22 psychoactive medicinal and illicit drugs, ethanol and phosphatidylethanol 16:0/18:1. Regression analyses were conducted to assess associations between alcohol use and gender, age, injury mechanism and drug use. Results and Conclusion: Of the 4845 patients included in the study, 10% had PEth 16:0/18:1 concentration ≥ 600 nM (~430 ng/mL), indicative of excessive chronic alcohol use. Being male, between 44-61 years old, involved in violence, and testing positive for medicinal drugs was associated with excessive chronic alcohol use. Excessive chronic alcohol use was common among males, middle-aged, patients with violence as injury mechanism and those with medicinal drug use. These findings emphasize the need to detect and treat excessive chronic alcohol use among trauma patients.
- Open Access
- 14 October 2022
- Published by Elsevier in Journal of Chromatography A
- Vol. 1684, 463566
Determination of eight phosphatidylethanol homologues in blood by reversed phase liquid chromatography–tandem mass spectrometry – How to avoid co-elution of phosphatidylethanols and unwanted phospholipids
- 14 October 2022
- Published by Elsevier in Journal of Chromatography A
- Vol. 1684, 463566
Open AccessDetermination of eight phosphatidylethanol homologues in blood by reversed phase liquid chromatography–tandem mass spectrometry – How to avoid co-elution of phosphatidylethanols and unwanted phospholipids
- Open Access
- 12 July 2021
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 56 (11) , 1697-1706
Prevalence and Correlates of Illicit Drug Use among Norwegian Nightlife Patrons
Nightclubs and bars are recreational settings with extensive availability and consumption of alcohol and recreational drugs.This study aims to determine the proportion of nightclub patrons in Norwa...
- 12 July 2021
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 56 (11) , 1697-1706
Open AccessPrevalence and Correlates of Illicit Drug Use among Norwegian Nightlife Patrons
Nightclubs and bars are recreational settings with extensive availability and consumption of alcohol and recreational drugs.This study aims to determine the proportion of nightclub patrons in Norwa...
- Open Access
- 3 March 2021
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 56 (6) , 726-736
The Association between the Alcohol Biomarker Phosphatidylethanol (PEth) and Self-Reported Alcohol Consumption among Russian and Norwegian Medical Patients
Aims: Valid measures to identify harmful alcohol use are important. Alcohol Use Disorders Identification Test (AUDIT) is a validated questionnaire used to self-report harmful drinking in several cultures and settings. Phosphatidylethanol 16:0/18:1 (PEth) is a direct alcohol biomarker measuring alcohol consumption levels. The aim of this study was to investigate how PEth levels correlate with AUDIT-QF and weekly grams of alcohol consumed among patients in two urban hospitals. In addition, we wanted to investigate the predictive value of PEth in identifying harmful alcohol use as defined by AUDIT-QF and weekly grams of alcohol cutoffs. Methods: A cross-sectional study comprising acute medically ill patients with measurable PEth levels (≥0.030 μM) admitted to two urban hospitals in Oslo, Norway (N = 931) and Moscow, Russia (N = 953) was conducted using PEth concentrations in whole blood, sociodemographic data and AUDIT-QF questionnaires. Results: PEth levels from patients with measurable PEth were found to be positively correlated with AUDIT-QF scores, with PEth cutpoints of 0.128 μM (Oslo) and 0.270 μM (Moscow) providing optimal discrimination for harmful alcohol use defined by AUDIT-QF (the difference between cities probably reflecting different national drinking patterns in QF). When converting AUDIT-QF into weekly grams of alcohol consumed, the predictive value of PEth improved, with optimal PEth cutpoints of 0.327 (Oslo) and 0.396 (Moscow) μM discriminating between harmful and non-harmful alcohol use as defined in grams (≥350 grams/week). Conclusions: By using PEth levels and converting AUDIT-QF into weekly grams of alcohol it was possible to get an improved rapid and sensitive determination of harmful alcohol use among hospitalized patients.
- 3 March 2021
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 56 (6) , 726-736
Open AccessThe Association between the Alcohol Biomarker Phosphatidylethanol (PEth) and Self-Reported Alcohol Consumption among Russian and Norwegian Medical Patients
Aims: Valid measures to identify harmful alcohol use are important. Alcohol Use Disorders Identification Test (AUDIT) is a validated questionnaire used to self-report harmful drinking in several cultures and settings. Phosphatidylethanol 16:0/18:1 (PEth) is a direct alcohol biomarker measuring alcohol consumption levels. The aim of this study was to investigate how PEth levels correlate with AUDIT-QF and weekly grams of alcohol consumed among patients in two urban hospitals. In addition, we wanted to investigate the predictive value of PEth in identifying harmful alcohol use as defined by AUDIT-QF and weekly grams of alcohol cutoffs. Methods: A cross-sectional study comprising acute medically ill patients with measurable PEth levels (≥0.030 μM) admitted to two urban hospitals in Oslo, Norway (N = 931) and Moscow, Russia (N = 953) was conducted using PEth concentrations in whole blood, sociodemographic data and AUDIT-QF questionnaires. Results: PEth levels from patients with measurable PEth were found to be positively correlated with AUDIT-QF scores, with PEth cutpoints of 0.128 μM (Oslo) and 0.270 μM (Moscow) providing optimal discrimination for harmful alcohol use defined by AUDIT-QF (the difference between cities probably reflecting different national drinking patterns in QF). When converting AUDIT-QF into weekly grams of alcohol consumed, the predictive value of PEth improved, with optimal PEth cutpoints of 0.327 (Oslo) and 0.396 (Moscow) μM discriminating between harmful and non-harmful alcohol use as defined in grams (≥350 grams/week). Conclusions: By using PEth levels and converting AUDIT-QF into weekly grams of alcohol it was possible to get an improved rapid and sensitive determination of harmful alcohol use among hospitalized patients.
- Open Access
- 6 March 2020
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 6 (March) , 18
Predictors of tobacco smoking among acutely ill patients in a Moscow hospital: A cross-sectional study
Introduction: Tobacco smoking is a major preventable risk factor for noncommunicable diseases. The aim of this study was to investigate predictors of tobacco smoking among acute medically ill patients admitted to a Moscow hospital, and the association between smoking and alcohol use. Methods:...
- 6 March 2020
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 6 (March) , 18
Open AccessPredictors of tobacco smoking among acutely ill patients in a Moscow hospital: A cross-sectional study
Introduction: Tobacco smoking is a major preventable risk factor for noncommunicable diseases. The aim of this study was to investigate predictors of tobacco smoking among acute medically ill patients admitted to a Moscow hospital, and the association between smoking and alcohol use. Methods:...